What is INGENIA Therapeutics worth?
$100.0Mlast known valuation
INGENIA Therapeutics last raised $5.0M in its Early Stage VC (Jun 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for INGENIA Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Early Stage VC | $5.0M | ▮ | ▮ |
| Nov 2022 | Early Stage VC | $7.0M | ▮ | ▮ |
| Sep 2020 | Seed Round | $4.7M | ▮ | ▮ |
How INGENIA Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For INGENIA Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is INGENIA Therapeutics worth?
- INGENIA Therapeutics's last known valuation is $100.0M.
- How much has INGENIA Therapeutics raised?
- INGENIA Therapeutics has raised $17.0M in total funding across 3 recorded rounds.
- When did INGENIA Therapeutics last raise?
- INGENIA Therapeutics last raised in Jun 2024 (Early Stage VC), raising $5.0M.